window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 20, 2026

  • News
  • About Us
Contact Us

myTomorrows

  • Artificial Intelligence,Clinical Trials,Digital Health,Patient Centricity

    myTomorrows details methodology and adoption of its AI clinical trial pre-screening tool

    myTomorrows has shared new details on the methodology behind its [...]

    November 25, 2025
  • Artificial Intelligence,Clinical Development,Partnerships & Funding

    myTomorrows secures $29 million from Avego to expand global access to pre-approval treatments

    myTomorrows has raised $29 million from Avego to support its [...]

    November 11, 2025
  • Regulatory Affairs,Technology and platforms

    myTomorrows unveils new SaaS platform to streamline global expanded access programs

    Health tech company myTomorrows has launched a dedicated platform to [...]

    May 28, 2025
  • Clinical Trials,Drug Development,Patient Centricity

    myTomorrows tops 15,000 global patient matches for pre-approval treatment access

    Clinical trial platform’s AI and navigator-led model bridges gap in [...]

    May 20, 2025
  • Patient Centricity

    Global patient access gets boost with myTomorrows and Scout Clinical collaboration

    April 24, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Cereno Scientific publishes first peer-reviewed data on HDAC inhibitor CS014 showing antithrombotic effects without bleeding risk
    Categories: Biotech, Clinical Development, Drug Development, European biotech, Hematology, Research & Development, Respiratory
  • SPT Labtech adds automated Twist Bioscience NGS library preparation workflows to firefly platform
    Categories: Data Management, Genomics and sequencing, Research & Development, Technology and platforms
  • Almirall to launch phase 3 LumiNE study of lebrikizumab in nummular eczema
    Categories: Clinical Trials, Dermatology, Drug Development, European biotech, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top